NCT02662699

Brief Summary

Anemia is a common pathology in geriatrics. According to the World Health Organization it affects 23.9% of subjects over 60 years in the world, and 8% of patients over 60 years in Europe. A prevalence that increases with the age and twice in individuals over 85 years.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 7, 2016

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 25, 2016

Completed
8 months until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

May 19, 2017

Status Verified

May 1, 2017

Enrollment Period

1.3 years

First QC Date

January 7, 2016

Last Update Submit

May 18, 2017

Conditions

Anemia

Keywords

AnemiaHematologic DiseasesErythrocytesHemoglobinHemolytic

Outcome Measures

Primary Outcomes (1)

  • Laboratory tests

    1 hour after hospitalization

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Anemic patients

You may qualify if:

  • Adult over 75 years old, male or female

You may not qualify if:

  • Transfusion within 3 months, acute anemia / deglobulisation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Médecine Interne, diabète et maladies métaboliques - Médicale B

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

AnemiaHematologic DiseasesHemolysis

Condition Hierarchy (Ancestors)

Hemic and Lymphatic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Emmanuel ANDRES

    University Hospital, Strasbourg, France

    STUDY DIRECTOR

Central Study Contacts

Emmanuel ANDRES, MD, PhD

CONTACT

33 3 88 11 50 66Emmanuel.ANDRES@chru-strasbourg.fr

Mohamed Hassanine BEN MALEK, MD

CONTACT

33 3 6 75 44 30 79hassaninebenmalek@hotmail.fr

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2016

First Posted

January 25, 2016

Study Start

October 1, 2016

Primary Completion

January 1, 2018

Study Completion

January 1, 2018

Last Updated

May 19, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)